Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
Osteogenesis imperfecta (OI) is an inherited skeletal disorder that leads to bone fragility and multiple fractures. Given advances in the genetic understanding of existing phenotypes and newly discovered mutations, therapeutic management of OI has become challenging. Denosumab, a monoclonal antibody...
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Korean Society of Pediatric Endocrinology
2023-06-01
|
| Colecção: | Annals of Pediatric Endocrinology & Metabolism |
| Assuntos: | |
| Acesso em linha: | http://e-apem.org/upload/pdf/apem-2346058-029.pdf |